NCT05081427View on ClinicalTrials.gov

Non-invasive Biomarkers of Metabolic Liver Disease (NIMBLE) Study 1.2

CompletedOBSERVATIONAL

Enrollment

17

Participants

Timeline

Start Date

November 15, 2021

Primary Completion Date

June 30, 2022

Study Completion Date

June 30, 2022

Conditions

Nonalcoholic Fatty Liver

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

Foundation for the National Institutes of Health

OTHER

lead

Mayo Clinic

OTHER